<DOC>
	<DOCNO>NCT01430650</DOCNO>
	<brief_summary>The aim trial compare two different endometrial priming protocol - woman receive oral estrogen - woman receive transdermal estrogen</brief_summary>
	<brief_title>Endometrial Priming Embryo Transfer</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Permixon</mesh_term>
	<criteria>Women 1850 year old desire child need embryo transfer . Plasma prolactin less 30 . Uterine cavity allow pregnancy , body mass index 2030 . And sign consent inform . History estrogen dependent cancer , unknown origin vaginal bleeding . Ovarian cyst . Contraindications pregnant . Estrogen allergy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Oral estrogen</keyword>
	<keyword>transdermal estrogen</keyword>
	<keyword>endometrial priming</keyword>
</DOC>